Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...
Having worked with many pharmaceutical and biotech companies over the last few years as the co-organizer of our annual Controlled & Modified Drug Release Summit, the need for many of them to explore opportunities and invest in controlled release technologies...
Recent Comments